Chatham Capital Group’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-23,787
| Closed | -$531K | – | 173 |
|
|
2022
Q2 | $531K | Buy |
23,787
+30
| +0.1% | +$670 | 0.12% | 137 |
|
|
2022
Q1 | $597K | Buy |
23,757
+311
| +1% | +$7.82K | 0.12% | 136 |
|
|
2021
Q4 | $840K | Buy |
23,446
+35
| +0.1% | +$1.25K | 0.15% | 128 |
|
|
2021
Q3 | $997K | Buy |
23,411
+664
| +3% | +$28.3K | 0.19% | 112 |
|
|
2021
Q2 | $985K | Buy |
22,747
+2
| +0% | +$87 | 0.19% | 114 |
|
|
2021
Q1 | $928K | Buy |
+22,745
| New | +$928K | 0.19% | 113 |
|